We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X

Biosensors Market Size, Share & Growth Report

Biosensors Market Size, Share, Statistics, Industry Growth Analysis Report by Type, Product (Wearable, Non-wearable), Technology, Application (POC, Home Diagnostics, Research Lab, Environmental Monitoring, Food & Beverages, Biodefense) Global Growth Driver and Industry Forecast to 2030

Report Code: SE 3097 Apr, 2021, by marketsandmarkets.com

The global biosensors market was valued at USD 34.4 billion in 2025 and is estimated to reach USD 47.54 billion by 2030, registering a CAGR of 6.7% during the forecast period. The emergence of nanotechnology-based biosensors, significant technological advancements in the last few years, increasing use of biosensors to monitor glucose levels in individuals with diabetes, surging demand for home-based point of care devices and rising government initiatives toward diagnostics are driving the growth of the biosensors market. However, the slow rate of commercialization and reluctance in adopting new treatment practices, and high costs involved in R&D are expected to restrain the growth of the market. Emerging markets in developing countries, high-growth opportunities in the food industry and environmental monitoring applications, and high-growth opportunities in the wearable biosensors market are projected to offer lucrative opportunities for the players operating in the biosensors market during the forecast period. Government regulations-long certification and approval cycles and pricing pressure in the POC market are expected to be the prime challenges for the market players..


Biosensors Market

Attractive Opportunities in Biosensors Market


Biosensors Market

Biosensors Market Forecast to 2030

To know about the assumptions considered for the study, Request for Free Sample Report

Impact of AI on Biosensors Market

AI in biosensors technologies have changed the game of the biosensors market since it affected the precision and efficiency along with real-time data analysis. With machine learning algorithms, biosensors start identifying a pattern of signs, predict conditions, and eventually diagnose diseases with high sensitivity and specificity. Biosensors that are driven by artificial intelligence bring in a revolution in personalized medicine through continuous health monitoring for an early anomaly compared to performing invasive procedures. Further, AI improves interfacing biosensors with Internet-of-Things and wearable bioelectronics, while permitting incident-free gathering of data and remote patient monitoring. This technology is pushing the demand in healthcare, agriculture, and environmental monitoring making AI a significant contributor to the rapid growth and innovation in the biosensors market.


Biosensors Market

Market Dynamics:

Driver: Escalated demand for Point-of-Care  (POC) diagnostics.

Escalated demand for point-of-care diagnostics allows rapid and accurate disease detection and not depend on conventional laboratory-based diagnostics that are long drawn and labor-intensive, often requiring professionals to make them possible. Biosensors have formed the very nucleus of this revolution by giving real-time monitoring of several diseases such as diabetes, cardiovascular diseases, and infectious diseases. The pandemic an increase in the adoption rate of biosensors in PoC applications. A device that is common in glucose monitoring, pregnancy tests, and infectious disease detection kits would allow individuals and health care providers to make timely medical decisions.Technological advancements will further boost PoC biosensor demand, with miniaturization, nanotechnology, and wireless communication capabilities enhancing performance and usability. For example, wearable biosensors are revolutionizing chronic disease management by continuously monitoring glucose levels and heartbeats. Government and healthcare policies that support PoC diagnostics are also driving growth because they are crucial in developing regions where it is difficult to have access to centralized laboratories.Despite these advantages, other limitations such as cost and regulatory approvals still exist. However, the increasing preference towards decentralized health care solutions, home-based monitoring, and self-testing kits are expected to accelerate the biosensors market. Due to the fact that health care systems are gradually shifting towards patient-centric models, the role of biosensors in delivering real-time accessible, cost-effective diagnostics is expected to grow continuously, thus turning PoC Biosensors into one of the key drivers of growth in the market.

Restraint: High cost associated with advanced biosensing technologies

The biggest restraint in the biosensors market is the high cost associated with advanced biosensing technologies. Biosensors offer great benefits in disease detection and monitoring. However, their development is often a complex and expensive process. Production costs certainly increase with the use of sophisticated nanomaterials, microfabrication techniques, and artificial intelligence (AI) and Internet of Things (IoT) integration. Biosensors are also needed to be extremely sensitive and specific, an aspect that calls for substantial R&D input to make them accurate and reliable. This is one more reason that leads to the increased cost of biosensors, which in turn restrain their application, especially in low-income and developing regions.

More than the production costs, the maintenance and calibration costs constitute another financial burden for health care providers as well as customers. Biosensors require recalibration periodically to ensure accuracy, thereby increasing operational costs. In institutions of health care, budgetary constraints often prevent such institutions from implementing biosensor-based diagnostic systems, opting for traditional diagnostic techniques that are less expensive in the short term. The reimbursement policies for biosensor-based testing also vary from one healthcare system to another, which affects market penetration.The best way to break this restraint is by focusing on cost reduction strategies by biosensor manufacturers, including economies of scale, low-cost biocompatible materials, and reusable biosensors.

Opportunity : Integration with technologies such as AI and IoT

It is opening up new avenues for the biosensors market by integrating biosensors with AI and IoT. The AI-based biosensors improve the accuracy of diagnostics by analyzing billions of biological data sets and detecting disease patterns with high precision. Such intelligent systems can sense the faint variations of the vital signs of a patient and help give early warnings regarding potential health risks, such as chronic diseases, including diabetes, cardiovascular ailments, and neurological disorders.The IoT-based biosensors further advance healthcare. They allow real-time monitoring and remote management of patients by actually sending data to cloud platforms or mobile applications, thereby allowing the healthcare provider to track patients from anywhere. This is highly helpful for aged persons, remote location patients, and patients under long-term surveillance of hypertension, sleep disorders, or other such disorders. Additionally, the effortless communication between biosensors, smartphones, and medical data sources also enhance the patient compliance and involvement. As users will have immediate responses to their health-related queries through action-oriented insights.Aside from health, AI-IoT integrations are helping open applications in agricultural, environmental, and food security. Smart biosensors will be able to detect contaminants in water and soil for better resource management and safety in public health. Increased demand for personalized medicine, preventive healthcare, and smart diagnostics is likely to be further fuelled by AI-driven biosensors. Companies making an investment in AI and IoT-enabled biosensing technologies will achieve competitive advantage as these solutions would bring innovation to individual health outcomes while increasing the overall efficiency of the system..

Challenge: Lack of standardization and  Regulatory Compliance

The main obstacle to growth in the market for biosensors is regulatory and compliance issues. Since biosensors serve diverse application areas in medical diagnostics, they must have met certain regulatory demands for safety, accuracy, and effectiveness. Among these regulatory agencies are the FDA of the U.S., EMEA, and the health authorities worldwide that enforce tight testing and approval procedure before the sale of biosensors in the markets. This process is both time-consuming and costly, and hence it is delaying the product launch and increasing R&D expenditures for manufacturers.Each country has different regulations that might make it a bit complicated for biosensor companies to access other international markets. For example, FDA approval in the United States may not allow a company to launch its biosensor in Europe or Asia, as those places have other frameworks of compliance. TAI-driven diagnostics require continuous learning and adaptation, so regulators must develop guidelines to ensure reliability but still leave room for innovation. Balancing strict safety requirements with technological advancement is still a challenge.To overcome these barriers, companies need to work closely with regulatory agencies from the early stages of product development to ensure compliance and accelerate approval processes. Streamlining regulatory pathways and harmonizing global standards could reduce market entry challenges significantly, thereby promoting innovation and wider adoption of biosensor technologies.

Biosensors Market Ecosystem

The biosensors market is competitive. Major companies, such as Abbott (US), Roche (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories (US), and DuPont (US) among others, are the major providers of biosensors. The market has numerous small- and medium-sized vital enterprises. Many players offer components and technologies, while other players offer integration services. These integration services are required in various applications.

Biosensors Market by Ecosystem

Embedded devices in biosensors segment to account for largest market share

Embedded devices for the biosensors market are considered to be among the largest since they play such a critical role in real-time health monitoring and diagnostics, particularly in medical research. These highly compact, highly integrated systems facilitate biosensor operation by allowing prompt data acquisition and processing and wireless communication. Their potential applications in wearable electronic health devices, point-of-care diagnostics, and continuous glucose monitoring make them a force in the markets.Technological improvements in the capabilities of microcontrollers, low-power sensors, and AI-driven analytics allow for more efficient and accurate embedded biosensing. The rising incidence of diseases such as diabetes and cardiovascular disorders will further enhance demand, as these devices can provide real-time, non-invasive monitoring solutions. This is because the trend of personalized medicine and remote patient monitoring is growing, and IoT-based healthcare solutions are expanding.Government initiatives toward digital healthcare along with increased R&D investments by key market players further add to the supremacy of the embedded devices. The present time dominance by the embedded biosensors is most likely to continue with regard to continuous, connected, and AI-enhanced monitoring in the healthcare sector..

Point of care application segment held largest share of biosensors during forecast period

The largest market share of biosensors will be contributed by a point-of-care application for its timely, accurate, and real-time diagnostic results. The utmost utilization of biosensors is observed in every clinical setting for remote patient monitoring and home healthcare. The early detection of diseases is possible through such biosensors and thus provides more effective management of treatment and care. Their growing adoption for glucose sensing & monitoring, infectious disease detection, pregnancy tests, and cardiac marker analysis is the reason for this accelerated market growth.Microfluidics, nanotechnology, and miniaturization of biosensors have greatly improved sensitivity and reliability with PoC diagnostics. Chronic diseases, including diabetes, cardiovascular disorders, and infections, also became very popular and fueled demand for PoC biosensors since they did not need central laboratories to make them dependent on those networks anymore. Market growth is further supported by personalized medicine and decentralized health solutions, as well as the effectiveness of government assistance in making diagnostics more accessible. Innovation through biosensors attached to smartphones and PoC devices powered by AI increases usability and allows for the real-time sharing of information with the healthcare provider. Increasing demand for rapid, portable diagnostic solutions will place PoC biosensors at the helm of the market and transform global health care delivery systems..

North America to contribute largest market share in biosensors market

North America is a leader in the biosensors market due to developed healthcare infrastructure, increasing chronic diseases, and aggressive R&D spends. North America is witnessing a high demand for point-of-care diagnostics, with increased focus on early disease diagnosis and personalized medicine. Growing incidence of diabetes, cardiovascular diseases, and cancer is driving the use of biosensors for continuous glucose monitoring (CGM), cardiac biomarker detection, and infectious disease diagnosis. Firms such as Abbott (and Dexcom are currently dominating the market with cutting-edge wearable biosensors for continuous health monitoring in real-time. In addition to this, private and government investments have a significant share in market expansion, with bodies like the NIH, FDA, and DARPA investing in nanotechnology, AI-based diagnosis, and biosensor miniaturization research.The ever-growing demand for digital health technologies and intelligent wearables propels the market further. Apart from healthcare, biosensors are seeing wider applications in food safety and environmental monitoring, helping detect pathogens, toxins, and contaminants. As there is wider integration of AI, cloud computing, and IoT, biosensors in North America are also becoming increasingly specific and affordable. With an increasing need for non-invasive, real-time monitoring solutions, North America is expected to keep dominating the global biosensors market.

Biosensors Market by Region

Biosensors Market Highlights

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Biosensors Market Report Scope :

Report Metric

Details

Estimated Market Size USD 34.4 Billion
Projected Market Size USD 47.54 Billion
Growth Rate 6.7%

Historical Data Available for Years

2025-2030

Base year considered

2024

Forecast period

2025-2030

 

Segments covered

  • By Type,
  • By Product,
  • By Technology,
  • By Application

Region Covered

  • North America,
  • Europe,
  • APAC,
  •  RoW

 

 

Market Leaders

  • Abbott (US),
  • Roche (Switzerland),
  • Medtronic (Ireland),
  • Bio-Rad Laboratories, Inc. (US),
  • DuPont (US),
  • Biosensors International Group, Ltd. (Singapore), Cytiva (UK),
  • Dexcom, Inc. (US),
  • Lifescan IP Holdings, LLC (US),
  • Masimo (US),
  • Nova Biomedical (US),
Largest Growing Region Asia Pacific
Largest Market Share Segment Embedded device
Highest CAGR Segment Wearable Biosensors
Largest Application Market Share Home diagnostic

The study categorizes the biosensors market  based on type, product, Trends, technology, and application at the regional and global level.

Aspect

Details

Biosensors Market, By Type

  • Sensor Patch
  • Embedded Device

Market, By Product

  • Wearable Biosensors
  • Non-wearable Biosensors

Market, By Technology

  • Electrochemical Biosensors
  • Optical Biosensors
  • Piezoelectric Biosensors
  • Thermal Biosensors
  • Nanomechanical Biosensors

Market, By Application

  • POC
  • Home Diagnostics
  • Research Labs
  • Environmental Monitoring
  • Food & Beverages
  • Biodefense

Biosensors Market, By Region

  • North America
  • Europe
  • APAC
  • RoW

Recent Developments

  • In October 2024, STMicroelectronics launched the ST1VAFE3BX bio-sensing chip designed for next-gen healthcare wearable  such as smartwatches, sports bands, connected rings, and smart glasses. The chip integrates high-accuracy biopotential input with inertial sensing and an AI core for activity detection, offering enhanced performance with reduced power consumption.This highly integrated biosensor device combines input channel for cardio and neurological sensing with motion tracking and embedded AI core.
  • In October 2024, Bruker Corporation acquired Dynamic Biosensors GmbH, a Munich-based company in biosensor innovation. This acquisition enhances Bruker's biophysical portfolio, providing advanced insights into molecular interactions and kinetics for drug discovery and research.
  • In April 2024, Biolinq Incorporated secured USD 58 million in financing, led by Alpha Wave Ventures, with contributions from Niterra’s corporate venture capital fund, Pegasus Tech Ventures, and other investors. J.P. Morgan acted as the placement agent for the funding round.

Frequently Asked Questions (FAQs):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

 

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 27)
    1.1 STUDY OBJECTIVES
    1.2 DEFINITION AND SCOPE
    1.3 STUDY SCOPE
           FIGURE 1 BIOSENSORS MARKET SEGMENTATION
           1.3.1 GEOGRAPHIC SCOPE
           1.3.2 INCLUSIONS AND EXCLUSIONS
    1.4 YEARS CONSIDERED
    1.5 CURRENCY
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 31)
    2.1 RESEARCH DATA
           FIGURE 2 BIOSENSORS MARKET: PROCESS FLOW OF MARKET SIZE ESTIMATION
           FIGURE 3 MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key industry insights
                    2.1.2.2 Breakdown of primaries
                    2.1.2.3 Key data from primary sources
    2.2 MARKET SIZE ESTIMATION
           FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: SUPPLY-SIDE ANALYSIS
           FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 (SUPPLY SIDE) – IDENTIFICATION OF REVENUES GENERATED BY COMPANIES FROM MICRO SERVER OFFERINGS
           2.2.1 BOTTOM-UP APPROACH
                    2.2.1.1 Approach for arriving at market size using bottom-up analysis (demand side)
                               FIGURE 6 MARKET: BOTTOM-UP APPROACH
                               FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR ESTIMATING SIZE OF BIOSENSORS MARKET
           2.2.2 TOP-DOWN APPROACH
                    2.2.2.1 Approach for arriving at market size using top-down analysis (supply side)
                               FIGURE 8 MARKET: TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
           TABLE 1 STUDY ASSUMPTIONS
    2.5 LIMITATIONS
           FIGURE 10 LIMITATIONS OF STUDY

3 EXECUTIVE SUMMARY (Page No. - 44)
    FIGURE 11 BIOSENSORS MARKET FOR SENSOR PATCH IS EXPECTED TO GROW AT HIGHER RATE DURING FORECAST PERIOD
    FIGURE 12 MARKET FOR WEARABLE BIOSENSORS IS EXPECTED TO GROW AT HIGHER RATE DURING FORECAST PERIOD
    FIGURE 13 MARKET FOR ELECTROCHEMICAL TECHNOLOGY TO HOLD LARGEST SHARE IN 2026
    FIGURE 14 POINT OF CARE APPLICATIONS HELD LARGEST SHARE OF MARKET IN 2021
    FIGURE 15 BIOSENSORS MARKET IN APAC TO GROW AT HIGHEST CAGR FROM 2021 TO 2026

4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 ATTRACTIVE OPPORTUNITIES IN BIOSENSORS MARKET
           FIGURE 16 RISING DEMAND FOR WEARABLE DEVICES ACROSS VARIOUS COUNTRIES TO IMPLEMENT MORE BIOSENSORS ACROSS POC AND HOME DIAGNOSTIC APPLICATIONS
    4.2 MARKET IN NORTH AMERICA, BY COUNTRY AND BY PRODUCT
           FIGURE 17 US AND NON-WEARABLE DEVICES ARE EXPECTED TO HOLD LARGEST SHARE OF NORTH AMERICAN BIOSENSORS MARKET IN 2021
    4.3 MARKET IN APAC, BY APPLICATION
           FIGURE 18 POC APPLICATION TO HOLD LARGEST SHARE OF MARKET IN APAC DURING FORECAST PERIOD
    4.4 MARKET, BY COUNTRY
           FIGURE 19 MARKET IN CHINA TO GROW AT HIGHEST CAGR FROM 2021 TO 2026

5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 20 INCREASED DEMAND FOR HOME-BASED POC DEVICES DUE TO COVID-19 PANDEMIC TO DRIVE MARKET FOR BIOSENSORS
           FIGURE 21 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MARKET
           5.2.1 DRIVERS
                    5.2.1.1 Emergence of nanotechnology-based biosensors
                    5.2.1.2 Significant technological advancements in last few years
                    5.2.1.3 Increasing use of biosensors to monitor glucose levels in individuals with diabetes
                    5.2.1.4 Surging demand for home-based point-of-care devices due to COVID-19 pandemic
                    5.2.1.5 Rising government initiatives toward diagnostics
           5.2.2 RESTRAINTS
                    5.2.2.1 Slow rate of commercialization and reluctance in adopting new treatment practices
                    5.2.2.2 High costs involved in R&D
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging market in developing countries
                    5.2.3.2 High-growth opportunities in food industry and environmental monitoring applications
                    5.2.3.3 High-growth opportunities in wearable device market
           5.2.4 CHALLENGES
                    5.2.4.1 Government regulations—long certification and approval cycles
                    5.2.4.2 Pricing pressure in POC market
    5.3 VALUE CHAIN ANALYSIS
           FIGURE 22 BIOSENSOR MANUFACTURERS CONTRIBUTE MAJOR VALUE TO OVERALL COST OF BIOSENSORS
    5.4 BIOSENSORS ECOSYSTEM
           FIGURE 23 BIOSENSORS MARKET ECOSYSTEM
           TABLE 2 SUPPLY CHAIN
    5.5 PORTER’S FIVE FORCES ANALYSIS
           TABLE 3 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.5.1 DEGREE OF COMPETITION
           5.5.2 BARGAINING POWER OF SUPPLIERS
           5.5.3 BARGAINING POWER OF BUYERS
           5.5.4 THREAT FROM SUBSTITUTES
           5.5.5 THREAT FROM NEW ENTRANTS
    5.6 CASE STUDIES FOR BIOSENSORS MARKET
           5.6.1 I-STAT SYSTEM HELPS PATIENTS AT ROCHDALE URGENT CARE CENTER
           5.6.2 INTEGRATED HEALTH SOLUTION PROVIDED COST SAVINGS AND INCREASED EFFICIENCY
           5.6.3 REDUCING MATERNAL MORBIDITY AND MORTALITY THROUGH NON-INVASIVE HAEMOGLOBIN MONITORING
           5.6.4 IMPROVING MOBILITY FOR PATIENTS AND REDUCING FALSE ALARMS FOR STAFF AT SUB-ACUTE CHILDREN’S HOSPITAL
           5.6.5 ENABLING SEAMLESS DATA TRANSMISSION FROM PATIENT’S HOME
    5.7 TECHNOLOGY ANALYSIS
    5.8 AVERAGE SELLING PRICE (ASP) TREND ANALYSIS
           FIGURE 24 AVERAGE SELLING PRICE OF BIOSENSORS, BY PRODUCT (USD)
    5.9 TRADE ANALYSIS
           TABLE 4 EXPORT SCENARIO FOR HS CODE: 901890, BY COUNTRY, 2015–2019 (USD THOUSAND)
           TABLE 5 IMPORT SCENARIO FOR HS CODE: 901890, BY COUNTRY, 2015–2019 (USD THOUSAND)
    5.10 PATENT ANALYSIS
    5.11 STANDARDS AND REGULATIONS RELATED TO BIOSENSORS MARKET
    5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
                    FIGURE 25 REVENUE SHIFT FOR BIOSENSORS MARKET

6 BIOSENSORS MARKET, BY TYPE (Page No. - 74)
    6.1 INTRODUCTION
           FIGURE 26 BIOSENSORS MARKET FOR SENSOR PATCH IS EXPECTED TO GROW AT HIGHER RATE DURING FORECAST PERIOD
           TABLE 6 MARKET, BY TYPE, 2017–2020 (USD BILLION)
           TABLE 7 MARKET, BY TYPE, 2021–2026 (USD BILLION)
    6.2 SENSOR PATCH
           6.2.1 THESE DEVICES ASSIST PEOPLE IN SPECIALIZED PROFESSIONAL AND PERSONAL ACTIVITIES
                    FIGURE 27 MARKET FOR SENSOR PATCH IN NORTH AMERICA HOLDS LARGEST SHARE
                    TABLE 8 BIOSENSORS MARKET FOR SENSOR PATCH, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 9 MARKET FOR SENSOR PATCH, BY REGION, 2021–2026 (USD MILLION)
    6.3 EMBEDDED DEVICE
           6.3.1 THEY DETECT BROAD SPECTRUM OF BIOLOGICAL ANALYTES AND SHOW GREATER RESPONSES AND SUCCESS RATES IN MEDICAL LABORATORIES AND FOOD BIOANALYSES
                    TABLE 10 MARKET FOR EMBEDDED DEVICE, BY REGION,  2017–2020 (USD BILLION)
                    TABLE 11MARKET FOR EMBEDDED DEVICE, BY REGION, 2021–2026 (USD BILLION)

7 BIOSENSORS MARKET, BY PRODUCT (Page No. - 79)
    7.1 INTRODUCTION
           FIGURE 28 BIOSENSORS INDUSTRY FOR WEARABLE BIOSENSORS IS EXPECTED TO GROW AT HIGHER RATE DURING FORECAST PERIOD
           TABLE 12 MARKET, BY PRODUCT, 2017–2020 (USD BILLION)
           TABLE 13 MARKET, BY PRODUCT, 2021–2026 (USD BILLION)
           TABLE 14 BIOSENSORS MARKET, BY PRODUCT, 2020–2026 (MILLION UNITS)
    7.2 WEARABLE BIOSENSORS
           FIGURE 29 WEARABLE MARKET IN APAC IS EXPECTED TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
           TABLE 15 WEARABLE MARKET, BY REGION, 2017–2020 (USD BILLION)
           TABLE 16 WEARABLE MARKET, BY REGION, 2021–2026 (USD BILLION)
           TABLE 17 WEARABLE MARKET, BY TECHNOLOGY, 2017–2020 (USD BILLION)
           TABLE 18 WEARABLE BIOSENSORS MARKET, BY TECHNOLOGY, 2021–2026 (USD BILLION)
           7.2.1 WRISTWEAR
                    7.2.1.1 Offer real-time health and fitness tracking and monitoring
           7.2.2 EYEWEAR
                    7.2.2.1 Smart glasses and smart lenses to have significant presence in market in coming years
           7.2.3 FOOTWEAR
                    7.2.3.1 Help in monitoring kilometer run, calories burned, workout hours, blood pressure, and other fitness- and health-related data
           7.2.4 NECKWEAR
                    7.2.4.1 Trendy devices that can help monitor fitness
           7.2.5 BODYWEAR
                    7.2.5.1 Have potential to equip clothes used for daily wear with smart capabilities, making detection of body movements possible
           7.2.6 OTHERS
                    TABLE 19 WEARABLE MARKET, BY PRODUCT, 2017–2020 (USD BILLION)
                    TABLE 20 WEARABLE MARKET, BY PRODUCT, 2021–2026 (USD BILLION)
    7.3 NON-WEARABLE BIOSENSORS
           7.3.1 OFFER REAL-TIME ON-SITE MONITORING OF PRODUCTION PROCESSES
                    TABLE 21 NON-WEARABLE MARKET, BY REGION, 2017–2020 (USD BILLION)
                    TABLE 22 MARKET, BY REGION, 2021–2026 (USD BILLION)
                    TABLE 23 NON-WEARABLE BIOSENSORS , BY TECHNOLOGY, 2017–2020 (USD BILLION)
                    TABLE 24 NON-WEARABLE BIOSENSORS , BY TECHNOLOGY, 2021–2026 (USD BILLION)
    7.4 IMPACT OF COVID-19

8 BIOSENSORS MARKET, BY TECHNOLOGY (Page No. - 88)
    8.1 INTRODUCTION
           FIGURE 30 BIOSENSORS MARKET FOR ELECTROCHEMICAL TECHNOLOGY TO HOLD LARGEST SHARE IN 2026
           TABLE 25 MARKET, BY TECHNOLOGY, 2017–2020 (USD BILLION)
           TABLE 26 MARKET, BY TECHNOLOGY, 2021–2026 (USD BILLION)
    8.2 ELECTROCHEMICAL BIOSENSORS
           TABLE 27 BIOSENSORS MARKET FOR ELECTROCHEMICAL TECHNOLOGY, BY PRODUCT, 2017–2020 (USD BILLION)
           TABLE 28 MARKET FOR ELECTROCHEMICAL TECHNOLOGY, BY PRODUCT, 2021–2026 (USD BILLION)
           8.2.1 AMPEROMETRIC SENSORS
                    8.2.1.1 Blood glucose sensors
                               8.2.1.1.1 Suitable for medical devices for monitoring blood glucose
                                             TABLE 29 GLUCOSE SENSORS AND DEVICES APPROVED BY FDA DURING 2019–2020
           8.2.2 POTENTIOMETRIC SENSORS
                    8.2.2.1 Immunosensors
                               8.2.2.1.1 Enable label-free detection and quantification of immune complex
           8.2.3 CONDUCTOMETRIC SENSORS
                    8.2.3.1 Conductometric devices can be used to study enzymatic reactions and for practical applications, including drug detection in human urine and pollutant detection in environmental testing
    8.3 OPTICAL BIOSENSORS
           FIGURE 31 OPTICAL TECHNOLOGY FOR WEARABLE DEVICES IS EXPECTED TO EXPERIENCE HIGHEST GROWTH RATE IN  MARKET DURING FORECAST PERIOD
           TABLE 30 MARKET FOR OPTICAL TECHNOLOGY, BY PRODUCT, 2017–2020 (USD BILLION)
           TABLE 31 BIOSENSORS MARKET FOR OPTICAL TECHNOLOGY, BY PRODUCT, 2021–2026 (USD BILLION)
           8.3.1 SPR
                    8.3.1.1 Measure interactions in real-time with high sensitivity and without needing labels
           8.3.2 COLORIMETRIC BIOSENSORS
                    8.3.2.1 Used in various applications, such as detection and identification of virulence activities
           8.3.3 FLUORESCENCE BIOSENSORS
                    8.3.3.1 Provide better sensitivities and specificities, as well as ease of labeling, while detection
    8.4 PIEZOELECTRIC BIOSENSORS
           TABLE 32 BIOSENSORS INDUSTRY FOR PIEZOELECTRIC TECHNOLOGY, BY PRODUCT, 2017–2020 (USD BILLION)
           TABLE 33 MARKET FOR PIEZOELECTRIC TECHNOLOGY, BY PRODUCT, 2021–2026 (USD BILLION)
           8.4.1 ACOUSTIC BIOSENSORS
                    8.4.1.1 Monitor changes in physical properties of acoustic waves in response to measurand
           8.4.2 MICROCANTILEVER BIOSENSORS
                    8.4.2.1 Promising tool for detecting biomolecular interactions with improved accuracy
    8.5 THERMAL BIOSENSORS
           8.5.1 DO NOT REQUIRE FREQUENT RECALIBRATION AND ARE INSENSITIVE TO OPTICAL AND ELECTROCHEMICAL PROPERTIES OF SAMPLE
                    TABLE 34 MARKET FOR THERMAL TECHNOLOGY, BY PRODUCT, 2017–2020 (USD BILLION)
                    TABLE 35 MARKET FOR THERMAL TECHNOLOGY, BY PRODUCT, 2021–2026 (USD BILLION)
    8.6 NANOMECHANICAL BIOSENSORS
           8.6.1 HAVE ABILITY TO PERFORM RAPID, SENSITIVE, AND SELECTIVE DETECTION OF BIOLOGICAL AND BIOCHEMICAL ENTITIES
                    TABLE 36 MARKET FOR NANOMECHANICAL TECHNOLOGY, BY PRODUCT, 2017–2020 (USD BILLION)
                    TABLE 37 BIOSENSOR MARKET FOR NANOMECHANICAL TECHNOLOGY, BY PRODUCT, 2021–2026 (USD BILLION)

9 BIOSENSORS MARKET, BY COMPONENT (Page No. - 100)
    9.1 INTRODUCTION
    9.2 BIORECEPTOR MOLECULES
           9.2.1 PRESENTLY, ANTIBODIES AND PROTEINS ARE ALSO USED AS BIORECEPTOR MOLECULES IN BIOSENSORS
    9.3 BIOLOGICAL ELEMENT
           9.3.1 BIOLOGICAL ELEMENTS ARE MATERIALS RELATED TO BIOMOLECULES
    9.4 TRANSDUCER
           9.4.1 TRANSDUCER IS MOST IMPORTANT COMPONENT OF BIOSENSORS, IT COVERTS BIOCHEMICAL ACTIVITIES INTO ELECTRICAL SIGNALS

10 BIOSENSORS MARKET, BY APPLICATION (Page No. - 101)
     10.1 INTRODUCTION
               FIGURE 32 POINT OF CARE APPLICATIONS HELD LARGEST MARKET SHARE OF BIOSENSORS MARKET IN 2021
               TABLE 38  MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
               TABLE 39 MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
     10.2 POC
               TABLE 40 BIOSENSORS INDUSTRY FOR POC APPLICATION, BY TYPE, 2017–2020 (USD BILLION)
               TABLE 41 MARKET FOR POC APPLICATION, BY TYPE, 2021–2026 (USD BILLION)
               TABLE 42 BIOSENSOR MARKET FOR POC APPLICATION, BY REGION, 2017–2020 (USD BILLION)
               TABLE 43 BIOSENSOR MARKET FOR POC APPLICATION, BY REGION, 2021–2026 (USD BILLION)
             10.2.1 GLUCOSE MONITORING
                       10.2.1.1 Rising prevalence of diabetes worldwide, technological advancements in self-monitoring of blood glucose, and growing awareness about PoC testing
                                   TABLE 44 BIOSENSOR MARKET FOR GLUCOSE MONITORING FOR POC APPLICATION, BY REGION, 2017–2020 (USD BILLION)
                                   TABLE 45  MARKET FOR GLUCOSE MONITORING FOR POC APPLICATION, BY REGION, 2021–2026 (USD BILLION)
             10.2.2 CARDIAC MARKER
                       10.2.2.1 Sedentary urban lifestyles causing increase in cardiovascular diseases
                                   TABLE 46 MARKET FOR CARDIAC MARKER FOR POC APPLICATION,  BY REGION, 2017–2020 (USD MILLION)
                                   TABLE 47 MARKET FOR CARDIAC MARKER FOR POC APPLICATION,  BY REGION, 2021–2026 (USD MILLION)
             10.2.3 INFECTIOUS DISEASE DETECTION
                       10.2.3.1 Detection of toxins, bacteria, and viruses in variety of physiological and environmental matrices
                                   FIGURE 33 INFECTIOUS DISEASE DETECTION OF POC APPLICATION HOLDS LARGEST MARKET SHARE ACROSS NORTH AMERICA DURING FORECAST PERIOD
                                   TABLE 48 MARKET FOR INFECTIOUS DISEASE DETECTION FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                                   TABLE 49 MARKET FOR INFECTIOUS DISEASE DETECTION FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
             10.2.4 COAGULATION MONITORING
                       10.2.4.1 Growing use of anticoagulant therapy, coupled with adoption of self-testing kits for use at home
                                   TABLE 50 BIOSENSORS MARKET FOR COAGULATION MONITORING FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                                   TABLE 51 MARKET FOR COAGULATION MONITORING FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
             10.2.5 PREGNANCY TESTING
                       10.2.5.1 Growing preference of women for confidentiality and accessibility of test results
                                   TABLE 52 BIOSENSORS INDUSTRY FOR PREGNANCY TESTING FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                                   TABLE 53 MARKET FOR PREGNANCY TESTING FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
             10.2.6 BLOOD GAS & ELECTROLYTE DETECTION
                       10.2.6.1 Growing global aging population is significantly driving growth of market
                                   TABLE 54 BIOSENSORS MARKET FOR BLOOD GAS & ELECTROLYTE DETECTION FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                                   TABLE 55 MARKET FOR BLOOD GAS & ELECTROLYTE DETECTION FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
             10.2.7 DETECTION OF TUMOR OR CANCER MARKER
                       10.2.7.1 Increasing number of people suffering from cancer and growth in investments in cancer research
                                   TABLE 56 MARKET FOR TUMOR OR CANCER MARKER FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                                   TABLE 57 BIOSENSORS MARKET FOR TUMOR OR CANCER MARKER FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
             10.2.8 URINALYSIS TESTING
                       10.2.8.1 Rising number of urinary tract infections among individuals
                                   TABLE 58 MARKET FOR URINALYSIS TESTING FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                                   TABLE 59 MARKET FOR URINALYSIS TESTING FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
             10.2.9 CHOLESTEROL TESTING
                       10.2.9.1 Increasing prevalence of CVDs due to aging and obese population
                                   TABLE 60 MARKET FOR CHOLESTEROL TESTING FOR POC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                                   TABLE 61 MARKET FOR CHOLESTEROL TESTING FOR POC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
     10.3 HOME DIAGNOSTICS
               TABLE 62 BIOSENSORS INDUSTRY FOR HOME DIAGNOSTICS APPLICATION, BY TYPE, 2017–2020 (USD MILLION)
               TABLE 63 MARKET FOR HOME DIAGNOSTICS APPLICATION, BY TYPE, 2021–2026 (USD MILLION)
               FIGURE 34 MARKET FOR HOME DIAGNOSTIC APPLICATIONS IN APAC IS EXPECTED TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
               TABLE 64 MARKET FOR HOME DIAGNOSTICS APPLICATION, BY REGION. 2017–2020 (USD BILLION)
               TABLE 65 MARKET FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2021–2026 (USD BILLION)
             10.3.1 GLUCOSE MONITORING
                       10.3.1.1 Growing preference for self-monitoring blood glucose devices
                                   TABLE 66 MARKET FOR GLUCOSE MONITORING FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2017–2020 (USD BILLION)
                                   TABLE 67 BIOSENSORS MARKET FOR GLUCOSE MONITORING FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2021–2026 (USD BILLION)
             10.3.2 PREGNANCY TESTING
                       10.3.2.1 Need for portable and user-friendly pregnancy testing devices
                                   TABLE 68 MARKET FOR PREGNANCY TESTING FOR HOME DIAGNOSTIC APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                                   TABLE 69 MARKET FOR PREGNANCY TESTING FOR HOME DIAGNOSTIC APPLICATION, BY REGION, 2021–2026 (USD MILLION)
             10.3.3 CHOLESTEROL TESTING
                       10.3.3.1 Growth of diseases due to increased cholesterol levels in individuals
                                   TABLE 70 MARKET FOR CHOLESTEROL TESTING FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                                   TABLE 71 MARKET FOR CHOLESTEROL TESTING FOR HOME DIAGNOSTICS APPLICATION, BY REGION, 2021–2026 (USD MILLION)
     10.4 RESEARCH LABS
             10.4.1 NEED FOR BIOSENSOR-BASED PRODUCT DEVELOPMENT FOR EARLY MONITORING OF DISEASES
                       TABLE 72 MARKET FOR RESEARCH LAB APPLICATION, BY REGION, 2017–2020 (USD BILLION)
                       TABLE 73 MARKET FOR RESEARCH LAB APPLICATION, BY REGION, 2021–2026 (USD BILLION)
     10.5 ENVIRONMENTAL MONITORING
             10.5.1 DETECTION OF CONTAMINANTS IN COMPLEX MATRICES WITH SEVERAL ADVANTAGES TO ENHANCE MARKET GROWTH
                       TABLE 74 MARKET FOR ENVIRONMENTAL MONITORING APPLICATION, BY REGION, 2017–2020 (USD BILLION)
                       TABLE 75 BIOSENSORS INDUSTRY FOR ENVIRONMENTAL MONITORING APPLICATION, BY REGION, 2021–2026 (USD BILLION)
     10.6 FOOD & BEVERAGES
             10.6.1 BIOSENSORS ARE USED FOR PATHOGEN DETECTION AND ARE HELPING TO MEET STRINGENT FOOD STANDARDS
                       TABLE 76  MARKET FOR FOOD & BEVERAGES APPLICATION, BY REGION, 2017–2020 (USD BILLION)
                       TABLE 77 MARKET FOR FOOD & BEVERAGES APPLICATION, BY REGION, 2021–2026 (USD BILLION)
     10.7 BIODEFENSE
             10.7.1 USE OF BIOSENSORS TO DETECT MICROBIAL PATHOGENS DURING BIOLOGICAL WARFARE
                       TABLE 78 MARKET FOR BIODEFENSE APPLICATION, BY REGION, 2017–2020 (USD MILLION)
                       TABLE 79 MARKET FOR BIODEFENSE APPLICATION, BY REGION, 2021–2026 (USD MILLION)

11 GEOGRAPHIC ANALYSIS (Page No. - 124)
     11.1 INTRODUCTION
               FIGURE 35 NORTH AMERICA HOLDS LARGEST SHARE OF BIOSENSORS MARKET
               TABLE 80 MARKET BY REGION, 2017–2020 (USD BILLION)
               TABLE 81 MARKET BY REGION, 2021–2026 (USD BILLION)
     11.2 NORTH AMERICA
               FIGURE 36 SNAPSHOT: BIOSENSORS MARKET IN NORTH AMERICA
               TABLE 82 MARKET IN NORTH AMERICA, BY APPLICATION, 2017–2020 (USD BILLION)
               TABLE 83 MARKET IN NORTH AMERICA, BY APPLICATION, 2021–2026 (USD BILLION)
               TABLE 84 MARKET IN NORTH AMERICA, BY POC APPLICATION, 2017–2020 (USD BILLION)
               TABLE 85 MARKET IN NORTH AMERICA, BY POC APPLICATION, 2021–2026 (USD BILLION)
               TABLE 86 BIOSENSORS INDUSTRY IN NORTH AMERICA, BY HOME DIAGNOSTICS APPLICATION, 2017–2020 (USD MILLION)
               TABLE 87 MARKET IN NORTH AMERICA, BY HOME DIAGNOSTICS APPLICATION, 2021–2026 (USD MILLION)
               TABLE 88 MARKET FOR NORTH AMERICA, BY TYPE, 2017–2020 (USD BILLION)
               TABLE 89 BIOSENSORS MARKET FOR NORTH AMERICA, BY TYPE,  2021–2026 (USD BILLION)
               TABLE 90 MARKET FOR NORTH AMERICA, BY PRODUCT, 2017–2020 (USD BILLION)
               TABLE 91 MARKET FOR NORTH AMERICA, BY PRODUCT, 2021–2026 (USD BILLION)
               FIGURE 37 US HOLDS LARGEST SHARE OF BIOSENSORS MARKET
               TABLE 92 MARKET IN NORTH AMERICA, BY COUNTRY, 2017–2020 (USD BILLION)
               TABLE 93 BIOSENSORS MARKET IN NORTH AMERICA, BY COUNTRY, 2021–2026 (USD BILLION)
             11.2.1 US
                       11.2.1.1 Presence of key players that offer biosensor-based PoC applications in US
             11.2.2 CANADA
                       11.2.2.1 Increasing government support likely to escalate growth of biosensors market in Canada
             11.2.3 MEXICO
                       11.2.3.1 Use of biosensors to detect cardiovascular disorders propels market growth in Mexico
     11.3 EUROPE
               FIGURE 38 SNAPSHOT: BIOSENSOR MARKET IN EUROPE
               TABLE 94 MARKET IN EUROPE, BY APPLICATION, 2017–2020 (USD BILLION)
               TABLE 95 MARKET IN EUROPE, BY APPLICATION, 2021–2026 (USD BILLION)
               TABLE 96 BIOSENSORS MARKET IN EUROPE, BY POC APPLICATION, 2017–2020 (USD MILLION)
               TABLE 97 MARKET IN EUROPE, BY POC APPLICATION, 2021–2026 (USD MILLION)
               TABLE 98 MARKET IN EUROPE, BY HOME DIAGNOSTICS APPLICATION, 2017–2020 (USD MILLION)
               TABLE 99 MARKET IN EUROPE, BY HOME DIAGNOSTICS APPLICATION, 2021–2026 (USD MILLION)
               TABLE 100 MARKET IN EUROPE, BY TYPE, 2017–2020 (USD BILLION)
               TABLE 101  MARKET IN EUROPE, BY TYPE, 2021–2026 (USD BILLION)
               TABLE 102 BIOSENSORS INDUSTRY IN EUROPE, BY PRODUCT, 2017–2020 (USD BILLION)
               TABLE 103 MARKET IN EUROPE, BY PRODUCT, 2021–2026 (USD BILLION)
               TABLE 104 MARKET IN EUROPE, BY COUNTRY, 2017–2020 (USD BILLION)
               TABLE 105 MARKET IN EUROPE, BY COUNTRY, 2021–2026 (USD BILLION)
             11.3.1 GERMANY
                       11.3.1.1 Monitoring of chronic diseases to escalate biosensors market growth
             11.3.2 FRANCE
                       11.3.2.1 Technological advancements in healthcare systems drive growth of market in France
             11.3.3 UK
                       11.3.3.1 Rising cardiac diseases and aging population are factors driving market growth in UK
             11.3.4 ITALY
                       11.3.4.1 Growing private sector results in increasing demand for biosensors for various applications
             11.3.5 REST OF EUROPE
     11.4 APAC
               FIGURE 39 SNAPSHOT OF BIOSENSORS MARKET IN APAC
               TABLE 106 MARKET IN APAC, BY APPLICATION, 2017–2020 (USD BILLION)
               TABLE 107 MARKET IN APAC, BY APPLICATION, 2021–2026 (USD BILLION)
               TABLE 10MARKET IN APAC, BY POC APPLICATION, 2017–2020 (USD MILLION)
               TABLE 109 MARKET IN APAC, BY POC APPLICATION, 2021–2026 (USD MILLION)
               TABLE 110 MARKET IN APAC, BY HOME DIAGNOSTICS APPLICATION, 2017–2020 (USD MILLION)
               TABLE 111 MARKET IN APAC, BY HOME DIAGNOSTICS APPLICATION, 2021–2026 (USD MILLION)
               TABLE 112 MARKET IN APAC, BY TYPE, 2017–2020 (USD BILLION)
               TABLE 113 MARKET IN APAC, BY TYPE, 2021–2026 (USD BILLION)
               TABLE 114 MARKET IN APAC, BY PRODUCT, 2017–2020 (USD BILLION)
               TABLE 115 BIOSENSOR MARKET IN APAC, BY PRODUCT, 2021–2026 (USD BILLION)
               FIGURE 40 BIOSENSOR MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
               TABLE 116 BIOSENSORS MARKET IN APAC, BY COUNTRY, 2017–2020 (USD BILLION)
               TABLE 117 BIOSENSOR MARKET IN APAC, BY COUNTRY, 2021–2026 (USD BILLION)
             11.4.1 CHINA
                       11.4.1.1 Government initiatives toward creating better healthcare products and services likely to propel biosensors market growth in China
             11.4.2 JAPAN
                       11.4.2.1 Increase in standard of living, rise in health awareness, and surge in aging population are key factors driving growth of biosensors market in Japan
             11.4.3 INDIA
                       11.4.3.1 Growing population in India escalates demand for biosensors for healthcare services
             11.4.4 REST OF APAC
     11.5 ROW
               TABLE 118 BIOSENSORS MARKET IN ROW, BY APPLICATION, 2017–2020 (USD MILLION)
               TABLE 119 MARKET IN ROW, BY APPLICATION, 2021–2026 (USD MILLION)
               TABLE 120 MARKET IN ROW, BY POC APPLICATION, 2017–2020 (USD MILLION)
               TABLE 121 MARKET IN ROW, BY POC APPLICATION, 2021–2026 (USD MILLION)
               TABLE 122 MARKET IN ROW, BY HOME DIAGNOSTICS APPLICATION, 2017–2020 (USD MILLION)
               TABLE 123 MARKET IN ROW, BY HOME DIAGNOSTICS APPLICATION, 2021–2026 (USD MILLION)
               TABLE 124 BIOSENSORS INDUSTRY IN ROW, BY TYPE, 2017–2020 (USD BILLION)
               TABLE 125 MARKET IN ROW, BY TYPE, 2021–2026 (USD BILLION)
               TABLE 126 MARKET IN ROW, BY PRODUCT, 2017–2020 (USD BILLION)
               TABLE 127  MARKET IN ROW, BY PRODUCT, 2021–2026 (USD BILLION)
               TABLE 128 MARKET IN ROW, BY COUNTRY, 2017–2020 (USD BILLION)
               TABLE 129 BIOSENSORS MARKET IN ROW, BY COUNTRY, 2021–2026 (USD BILLION)
             11.5.1 SOUTH AMERICA
                       11.5.1.1 Growing environment-related concerns have boosted adoption of biosensors for environmental monitoring applications in South America
             11.5.2 MIDDLE EAST AND AFRICA
                       11.5.2.1 Significant government support and financial support from global firms for adoption of POC testing kits will drive market for biosensors across Middle East and Africa
     11.6 IMPACT OF COVID-19

12 COMPETITIVE LANDSCAPE (Page No. - 152)
     12.1 OVERVIEW
     12.2 MARKET EVALUATION FRAMEWORK
               TABLE 130 OVERVIEW OF STRATEGIES DEPLOYED BY KEY BIOSENSORS PLAYERS
             12.2.1 PRODUCT PORTFOLIO
             12.2.2 REGIONAL FOCUS
             12.2.3 MANUFACTURING FOOTPRINT
             12.2.4 ORGANIC/INORGANIC GROWTH STRATEGIES
     12.3 REVENUE ANALYSIS OF LEADING PLAYERS (2016–2020)
               FIGURE 41 FIVE YEAR REVENUE ANALYSIS OF TOP 5 PLAYERS IN BIOSENSORS MARKET
     12.4 MARKET SHARE ANALYSIS: BIOSENSORS MARKET, 2020
               TABLE 131 DEGREE OF COMPETITION
     12.5 COMPANY EVALUATION MATRIX
             12.5.1 STAR
             12.5.2 EMERGING LEADER
             12.5.3 PERVASIVE
             12.5.4 PARTICIPANT
                       FIGURE 42 COMPANY EVALUATION MATRIX, 2020
     12.6 STARTUP EVALUATION MATRIX
               TABLE 132 LIST OF STARTUP COMPANIES IN BIOSENSORS MARKET
             12.6.1 PROGRESSIVE COMPANY
             12.6.2 RESPONSIVE COMPANY
             12.6.3 DYNAMIC COMPANY
             12.6.4 STARTING BLOCK
                       FIGURE 43 STARTUP (SME) EVALUATION MATRIX, 2020
     12.7 COMPANY PRODUCT FOOTPRINT
               TABLE 133 COMPANY PRODUCT FOOTPRINT
               TABLE 134 FOOTPRINT OF DIFFERENT SENSOR TYPES BY DIFFERENT COMPANIES
               TABLE 135 FOOTPRINT OF DIFFERENT COMPANIES ACROSS DIFFERENT APPLICATIONS
               TABLE 136 REGIONAL FOOTPRINT OF DIFFERENT COMPANIES
     12.8 COMPETITIVE SITUATIONS AND TRENDS
             12.8.1 PRODUCT LAUNCHES AND DEVELOPMENTS
                       TABLE 137 PRODUCT LAUNCHES AND DEVELOPMENTS, 2020
             12.8.2 DEALS
                       TABLE 138 DEALS, 2019–2021

13 COMPANY PROFILES (Page No. - 169)
(Business Overview, Products Offered, Recent Developments, COVID-19 related developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
     13.1 KEY PLAYERS
             13.1.1 ABBOTT
                       TABLE 139 ABBOTT: BUSINESS OVERVIEW
                       FIGURE 44 ABBOTT: COMPANY SNAPSHOT
             13.1.2 ROCHE
                       TABLE 140 ROCHE: BUSINESS OVERVIEW
                       FIGURE 45 ROCHE: COMPANY SNAPSHOT
             13.1.3 MEDTRONIC
                       TABLE 141 MEDTRONIC: BUSINESS OVERVIEW
                       FIGURE 46 MEDTRONIC: COMPANY SNAPSHOT
             13.1.4 BIO-RAD LABORATORIES
                       TABLE 142 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
                       FIGURE 47 BIO-RAD LABORATORIES: COMPANY SNAPSHOT
             13.1.5 DUPONT
                       TABLE 143 DUPONT: BUSINESS OVERVIEW
                       FIGURE 48 DUPONT: COMPANY SNAPSHOT
             13.1.6 BIOSENSORS INTERNATIONAL GROUP
                       TABLE 144 BIOSENSORS INTERNATIONAL GROUP: BUSINESS OVERVIEW
             13.1.7 CYTIVA
                       TABLE 145 CYTIVA: BUSINESS OVERVIEW
             13.1.8 DEXCOM
                       TABLE 146 DEXCOM: BUSINESS OVERVIEW
                       FIGURE 49 DEXCOM: COMPANY SNAPSHOT
             13.1.9 LIFESCAN
                       TABLE 147 LIFESCAN: BUSINESS OVERVIEW
             13.1.10 MASIMO
                        TABLE 148 MASIMO: BUSINESS OVERVIEW
                        FIGURE 50 MASIMO: COMPANY SNAPSHOT
             13.1.11 NOVA BIOMEDICAL
                        TABLE 149 NOVA BIOMEDICAL: BUSINESS OVERVIEW
             13.1.12 UNIVERSAL BIOSENSORS
                        TABLE 150 UNIVERSAL BIOSENSORS: BUSINESS OVERVIEW
                        FIGURE 51 UNIVERSAL BIOSENSORS: COMPANY SNAPSHOT
     13.2 OTHER KEY PLAYERS
             13.2.1 ACON LABORATORIES
             13.2.2 CARDEA BIO
             13.2.3 CONDUCTIVE TECHNOLOGIES
             13.2.4 EARLYSENSE
             13.2.5 EASTPRINT INCORPORATED
             13.2.6 IST AG
             13.2.7 LIFESIGNALS
             13.2.8 NEUROSKY
             13.2.9 PINNACLE TECHNOLOGY
             13.2.10 SD BIOSENSOR
             13.2.11 VITALCONNECT
             13.2.12 XSENSIO
             13.2.13 ZIMMER AND PEACOCK

*Details on Business Overview, Products Offered, Recent Developments, COVID-19 related developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 222)
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.3 AVAILABLE CUSTOMIZATIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS

The study involved four major activities in estimating the biosensors market. Secondary and primary sources have been used to identify and collect information for an extensive technical and commercial study of the biosensors market. Validating findings, assumptions, and sizing with industry experts across the value chain through primary research has been the next step. Both top-down and bottom-up approaches have been employed to estimate the complete market size. After that, market breakdown and data triangulation methods have been used to estimate the market size of segments and subsegments. This research includes the study of annual reports of the market players to identify the top players, along with interviews of the key opinion leaders such as chief executive officers (CEOs), directors, and marketing personnel.

Secondary Research

In the secondary research process, various secondary sources were referred for identifying and collecting information for this study. The secondary sources include annual reports, press releases, and investor presentations of companies; white papers, journals and certified publications, and articles from recognized authors; and websites, directories, and databases. Secondary research has mainly been used to obtain key information about the industry’s supply chain, the market’s value chain, major players, market classification, and segmentation according to the industry trends to the bottommost level, geographic markets, and key developments from both markets- and technology-oriented perspectives. The secondary data has been collected and analyzed to arrive at the overall market size, which has further been validated by primary research. A few important secondary sources referred to for this research study are International Diabetes Federation (IDF), American Diabetes Association (ADA), and National Biodefense Analysis and Countermeasures Center (NBACC).

Primary Research

Extensive primary research has been conducted after acquiring knowledge about the biosensors market scenario through secondary research. Several primary interviews have been conducted with market experts from both supply (biosensor manufacturers) and demand (biosensor applications) sides across four major regions—North America, Europe, APAC, and RoW (including South America, the Middle East, and Africa). Approximately 30% of the primary interviews have been conducted with the demand side and 70% with the supply side. Primary data has been mainly collected through telephonic interviews, which consist of approximately 80% of the overall primary interviews. Moreover, questionnaires and emails have also been used to collect the data.

Biosensors Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

In the complete market engineering process, both top-down and bottom-up approaches have been used along with several data triangulation methods to perform the market estimation and forecasting for the overall market segments and subsegments listed in this report. The key players in the market have been identified through secondary research, and their market shares in the respective regions have been determined through primary and secondary research. The entire procedure includes the study of annual and financial reports of top market players and extensive interviews for key insights from industry experts, such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources. All the possible parameters affecting the markets covered in this research study have been accounted for, viewed in detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data has been consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets and presented in this report.

The bottom-up approach has been used to arrive at the overall size of the biosensors market from revenues of the key players and their shares in the market. The overall market size has been calculated based on the revenues of the key players identified in the market. The research methodology used to estimate the market size by the bottom-up approach includes the following:

  • Identifying key participants that influence the overall biosensors market, along with related component providers
  • Analyzing key providers of biosensors and biosensor components, along with raw material providers and studying their portfolios to understand the different components and products offered by them in addition to examining the developments undertaken by the key players during the pre-COVID-19 period, as well as studying the measures/steps undertaken by them to deal with COVID-19
  • Predicting the anticipated change in demand for biosensors and their components in the post-COVID-19 scenario
  • Analyzing trends pertaining to the use of biosensors in different applications such as point of care, home diagnostics, research lab, food & beverages, environmental monitoring, and biodefense.
  • Tracking the ongoing and identifying the upcoming developments in the market in the form of investments, R&D activities, product launches, collaborations, and partnerships, and forecasting the market based on these developments and other critical parameters
  • Carrying out multiple discussions with key opinion leaders to understand the various types of biosensors used in different applications and recent trends in the market, thereby analyzing the breakup of the scope of the work carried out by the leading companies
  • Arriving at the market estimates by analyzing the revenues generated by companies and combining the same to get the market estimates
  • Segmenting the overall market into different segments
  • Verifying and crosschecking estimates at every level through discussions with key opinion leaders such as CXOs, directors, and operations managers, and finally with the domain experts at MarketsandMarkets
  • Studying various paid and unpaid sources of information such as annual reports, press releases, white papers, and databases

In the top-down approach, the overall market size has been used to estimate the size of the individual markets (mentioned in the market segmentation) through percentage splits obtained from secondary and primary research. For the calculation of the sizes of specific market segments, the size of the most appropriate parent market has been considered to implement the top-down approach. Data from interviews have been consolidated, checked for consistency and accuracy, and inserted into a data model to arrive at the market numbers following the top-down approach. The market size in different regions has been identified and analyzed through secondary research.

Upon the estimation and validation of the size of the biosensors market, further segmentation has been carried out based on consolidated inputs from key players with respect to regional adoption trends of biosensors and pervasiveness of the different types of biosensors across different applications and regions.

The research methodology used to estimate the market size by the top-down approach includes the following:

  • Focusing on top-line investments and expenditures made in the biosensors market ecosystem
  • Calculating the market size considering revenues generated by the key players through the sales of biosensors and components; estimating the market size for 2020 by considering the impact of COVID-19 across the value chain of the biosensors market, and analyzing recovery scenarios across the world to further forecast the market size
  • Conducting multiple on-field discussions with key opinion leaders of key companies operating in the biosensors market to understand the pre-COVID-19 and post-COVID-19 scenarios
  • Estimating the geographic split using secondary sources based on various factors such as the demand for biosensors in a specific country and region, adoption rate across different products such as wearables and non-wearable biosensors for applications such as point of care, home diagnostics, research lab, food & beverages, environmental monitoring, and biodefense.

Data Triangulation

After arriving at the overall market size from the estimation process explained earlier, the overall market is split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all the segments and subsegments, the market breakdown and data triangulation procedures are employed, wherever applicable. The data is triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market size is validated using both top-down and bottom-up approaches.

Report Objectives

  • To describe and forecast the biosensors market, in terms of value, by type, product, technology, and application
  • To describe and forecast the biosensors market, in terms of value, by region—North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
  • To provide detailed information regarding major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micro markets with respect to individual growth trends, prospects, and contributions to the overall biosensors market
  • To analyze opportunities for stakeholders in the biosensors market by identifying the high-growth segments
  • To profile key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing the competitive landscape for market leaders
  • To analyze competitive developments such as mergers and acquisitions, expansions, product and service launches, partnerships, contracts, and agreements in the biosensors market

Available Customizations

With the given market data, MarketsandMarkets offers customizations according to the specific requirements of companies. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
SE 3097
Published ON
Apr, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biosensors Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
knowledgestore logo

Want to explore hidden markets that can drive new revenue in Biosensors Market?

Find Hidden Markets
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2025 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback